$2.66
0.06 (+2.31%)
Array BioPharma, Inc. (NASDAQ:ARRY)
CAPS Rating:
A biopharmaceutical company focused on the discovery, development and commercialization of targeted small molecule drugs to treat life threatening and debilitating diseases.
RSS Headlines
Fool UK